Mesa Laboratories reported $186.69M in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
3M USD 3.26B 1.48B Mar/2026
Agilent USD 6.91B 167M Dec/2025
Ametek USD 10.92B 290.51M Mar/2026
Amphenol USD 13.98B 563.7M Mar/2026
Becton, Dickinson and Co. USD 25.28B 108M Dec/2025
Bruker USD 2.49B 625.6M Sep/2025
Danaher USD 52.95B 415M Mar/2026
EDAP TMS EUR 23.32M 4.5M Sep/2025
Fortive USD 6.08B 370.3M Mar/2026
General Electric Aerospace USD 18.06B 841M Mar/2026
Mesa Laboratories USD 186.69M 8.22M Dec/2025
Mettler Toledo International USD -23.64M 225.56M Dec/2025
OraSure Technologies USD 340.83M 21.15M Dec/2025
Revvity USD 7.25B 125.54M Dec/2025
Steris USD 7.15B 145.4M Dec/2025
Surmodics USD 111.31M 7.59M Jun/2025
Teleflex USD 3.12B 697.09M Dec/2025
Thermo Fisher Scientific USD 51.93B 1.6B Mar/2026
Trinity Biotech USD -54.72M 5.18M Sep/2025
Waters USD 2.56B 230.55M Dec/2025